MedPath

Shanton Pharma Co., Ltd.

Shanton Pharma Co., Ltd. logo
🇨🇳China
Ownership
Holding
Established
2016-02-05
Employees
1
Market Cap
-
Website
https://shantonpharma.com

Clinical Trials

4

Active:1
Completed:3

Trial Phases

2 Phases

Phase 1:2
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
2 (50.0%)

SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects

Phase 1
Completed
Conditions
Gout
Hyperuricemia
Interventions
Drug: Placebo
First Posted Date
2024-11-07
Last Posted Date
2024-11-12
Lead Sponsor
Shanton Pharma Co., Ltd.
Target Recruit Count
70
Registration Number
NCT06678581
Locations
🇨🇳

Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China

Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Phase 2
Active, not recruiting
Conditions
Gout
Interventions
First Posted Date
2023-01-19
Last Posted Date
2024-11-14
Lead Sponsor
Shanton Pharma Pte. Ltd.
Target Recruit Count
87
Registration Number
NCT05690204
Locations
🇺🇸

California Site, San Diego, California, United States

🇺🇸

Denver Site, Denver, Colorado, United States

🇺🇸

Florida Site, Winter Park, Florida, United States

and more 6 locations

Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients

Phase 2
Completed
Conditions
Gout
Hyperuricemia
Interventions
First Posted Date
2019-08-01
Last Posted Date
2021-11-05
Lead Sponsor
Shanton Pharma Co., Ltd.
Target Recruit Count
40
Registration Number
NCT04040816
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Anaheim Clinical Trials (ACT), Anaheim, California, United States

🇺🇸

Miami Research Associates, South Miami, Florida, United States

and more 3 locations

Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients

Phase 1
Completed
Conditions
Gout, Hyperuricemia
Interventions
First Posted Date
2019-02-27
Last Posted Date
2021-10-14
Lead Sponsor
Shanton Pharma Co., Ltd.
Target Recruit Count
24
Registration Number
NCT03857165
Locations
🇺🇸

Anaheim Clinical Trials, LLC, Anaheim, California, United States

🇺🇸

Avail - Accel Research Sites, DeLand, Florida, United States

🇺🇸

High Point Clinical Trials Center, High Point, North Carolina, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath